Trial Profile
A phase II study of lopinavir/ritonavir in combination with saquinavir mesylate or lamivudine/zidovudine to explore metabolic toxicities in antiretroviral HIV-infected subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2008
Price :
$35
*
At a glance
- Drugs Lamivudine/zidovudine (Primary) ; Lopinavir/ritonavir (Primary) ; Saquinavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 19 Oct 2005 New trial record.